Template:Approval and deployment of COVID-19 vaccines in Canada

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
COVID-19 vaccines on order in Canada ()
Vaccine Progress Doses ordered Approval Deployment
Pfizer–BioNTech phase III clinical trials 48-76 million[1][2] Green check.svg 9 December 2020[3] Green check.svg 14 December 2020
Moderna phase III clinical trials 44 million[4] Green check.svg 23 December 2020[5] Green check.svg 31 December 2020
Oxford–AstraZeneca phase III clinical trials 23.9 million[6] Green check.svg 26 February 2021[7] Green check.svg 10 March 2021[8]
Janssen (Johnson & Johnson) phase III clinical trials 10-38 million Green check.svg 5 March 2021[9] Pending
Novavax phase III clinical trials up to 76 million Pending Pending
Medicago phase III clinical trials[10] up to 76 million Pending Pending
Sanofi–GSK phase III clinical trials up to 72 million Pending Pending

References

  1. ^ "Government secures another 20M COVID-19 vaccine doses from Pfizer". Retrieved March 22, 2021.
  2. ^ https://www.canada.ca/en/public-services-procurement/services/procuring-vaccines-covid19.html
  3. ^ "Health Canada approves Pfizer's COVID-19 vaccine". thestar.com. December 9, 2020.
  4. ^ "Canada Purchases Additional 4 Million Doses of Moderna's COVID-19 Vaccine". www.businesswire.com. February 12, 2021.
  5. ^ "Shipment of Moderna COVID-19 vaccine arrives in Canada one day after approval". CBC News. December 24, 2020. Retrieved February 18, 2021.
  6. ^ "Health Canada approves two AstraZeneca COVID-19 vaccines". Coronavirus. February 26, 2021.
  7. ^ Tasker, John Paul (February 26, 2021). "Health Canada approves AstraZeneca's COVID-19 vaccine". CBC. Retrieved March 22, 2021.
  8. ^ "Shoppers Drug Mart marks historic COVID-19 milestone with first vaccine in pharmacy in Ontario". Newswire. Retrieved March 22, 2021.
  9. ^ Zimonjic, Peter (September 17, 2020). "Drug and vaccine authorizations for COVID-19: List of authorized drugs, vaccines and expanded indications March 3, 2021". AEM. Retrieved March 22, 2021.
  10. ^ "Medicago and GSK start Phase 3 trial of adjuvanted COVID-19 vaccine candidate". Retrieved March 22, 2021.